Literature DB >> 3458590

Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits.

J C Stavridis, G Deliconstantinos, M C Psallidopoulos, N A Armenakas, D J Hadjiminas, J Hadjiminas.   

Abstract

A method for coating liposomes with transferrin is described. Such liposomes have been used for carrying exogenous DNA to rabbit bone marrow (BM) precursor cells, in vivo. A large amount of the DNA contained in the liposomes was delivered specifically into the erythroblasts of the test animals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458590     DOI: 10.1016/0014-4827(86)90056-x

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

Authors:  Lloyd B Jeffs; Lorne R Palmer; Ellen G Ambegia; Cory Giesbrecht; Shannon Ewanick; Ian MacLachlan
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

2.  WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma.

Authors:  Santiago Saavedra-Alonso; Pablo Zapata-Benavides; Ana Karina Chavez-Escamilla; Edgar Manilla-Muñoz; Diana Elisa Zamora-Avila; Moisés Armides Franco-Molina; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2016-10-27       Impact factor: 2.447

3.  Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting.

Authors:  C Dufes; A G Schätzlein; L Tetley; A I Gray; D G Watson; J C Olivier; W Couet; I F Uchegbu
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

4.  Targeting of Synthetic Gene Delivery Systems.

Authors:  Andreas G. Schätzlein
Journal:  J Biomed Biotechnol       Date:  2003

Review 5.  Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.

Authors:  Md Emranul Karim; Kyi Kyi Tha; Iekhsan Othman; Mohammad Borhan Uddin; Ezharul Hoque Chowdhury
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.